SCHEMBL2313073

SCHEMBL2313073

OCCc1ccc2c3cccc4cccc(c5ccc(CCO)c1c25)c43

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.40
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
HSD17B10 Q99714 3/20 0.40
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
THRB P10828 1/20 0.40
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.37
MAOA P21397 1/20 0.37
ACHE P22303 1/20 0.37
AHR P35869 1/20 0.37
HTR2A P28223 4/20 0.35
KDM4E B2RXH2 2/20 0.33
GLA P06280 1/20 0.33
POLB P06746 1/20 0.33
CYP2D6 P10635 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
HEXA P06865 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2310217 0.91 KMT2A (0.44) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2309692 0.89 KMT2A (0.47) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2312283 0.87 ALDH1A1 (0.48) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2315939 0.86 ALDH1A1 (0.52) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2313987 0.85 CYP1A2 (0.40) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2310354 0.84 CYP1A2 (0.43) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2310469 0.83 CYP1A2 (0.43) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2314747 0.82 ALDH1A1 (0.46) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2308433 0.82 KMT2A (0.50) CYP1A2ALDH1A1HPGDHSD17B10KMT2A
SCHEMBL2307308 0.82 KMT2A (0.50) CYP1A2ALDH1A1HPGDHSD17B10KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed